Annual report
6823.TEDINET S100TRAL
Period2023-04-01 → 2024-03-31
Filed2024-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥25.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥23.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥22.6bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.5bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.5bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.5bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥2.8bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥3.6bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.0bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.2bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.6bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.5bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.6bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥37.1bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥34.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥33.2bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥30.7bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥29.9bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.9bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.9bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥29.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥26.6bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥25.3bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥23.7bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥22.2bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.4bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥4.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.2bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.8bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥5.5bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.8bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥2.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥952m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥970m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥566m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥577m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥542m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥566m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥529m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥215.51 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥146.33 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥181.41 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥133.27 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.96 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥2,372.88 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,163.3 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,057.4 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,931.15 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,810.87 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 78.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.0% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.3% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.3% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.5% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.9% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.1% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,026 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 998 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 954 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 932 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 916 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥21.0bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥18.5bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥18.2bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥16.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥17.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.8bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥2.1bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥4.2bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.6bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.9bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.3bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.1bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.0bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥3.4bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥2.1bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.4bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥34.3bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥30.7bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥29.9bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥27.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥26.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.4bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥6.6bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥26.9bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥24.0bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥23.0bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥21.5bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥20.4bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.7bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.7bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥278.19 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥129.53 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.29 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.15 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥137.39 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥55 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥43 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥43 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,188.6 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,954.68 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,872.33 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,750.31 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,659.3 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 78.5% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.4% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.1% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.0% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.9% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 13.4% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.5% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 12,327,900 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,319,100 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,309,100 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,303,400 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 12,294,400 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 508 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 495 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 504 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 502 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 501 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 60
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥238m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥63m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥8.0bn |
| Environmental Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥545m |
| Environmental Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥186m |
| Environmental Equipmentreportable segment | employees | at 2024-03-31 | 198 pure |
| Environmental Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Environmental Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥5.4bn |
| Environmental Equipmentreportable segment | segment assets | at 2024-03-31 | ¥7.5bn |
| Environmental Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥104m |
| Medical Equipmentreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Medical Equipmentreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥346m |
| Medical Equipmentreportable segment | employees | at 2024-03-31 | 566 pure |
| Medical Equipmentreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥12.7bn |
| Medical Equipmentreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥12.7bn |
| Medical Equipmentreportable segment | segment assets | at 2024-03-31 | ¥12.4bn |
| Medical Equipmentreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.3bn |
| Particle Countersreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥804m |
| Particle Countersreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥242m |
| Particle Countersreportable segment | employees | at 2024-03-31 | 153 pure |
| Particle Countersreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥7.6bn |
| Particle Countersreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥7.6bn |
| Particle Countersreportable segment | segment assets | at 2024-03-31 | ¥9.3bn |
| Particle Countersreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥2.1bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥2.5bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥774m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥25.7bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥25.7bn |
| —segment total | segment assets | at 2024-03-31 | ¥29.1bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥3.5bn |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥154m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥60m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥8.4bn |
| Environmental Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥429m |
| Environmental Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥142m |
| Environmental Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Environmental Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥5.1bn |
| Environmental Equipmentreportable segment | segment assets | at 2023-03-31 | ¥6.9bn |
| Environmental Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥300m |
| Medical Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥959m |
| Medical Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥315m |
| Medical Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥12.2bn |
| Medical Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥12.2bn |
| Medical Equipmentreportable segment | segment assets | at 2023-03-31 | ¥11.5bn |
| Medical Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.0bn |
| Particle Countersreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥534m |
| Particle Countersreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥199m |
| Particle Countersreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥6.6bn |
| Particle Countersreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥6.6bn |
| Particle Countersreportable segment | segment assets | at 2023-03-31 | ¥7.8bn |
| Particle Countersreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.5bn |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥656m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥23.9bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥23.9bn |
| —segment total | segment assets | at 2023-03-31 | ¥26.2bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥2.8bn |
| Environmental Equipmentreportable segment | employees | at 2024-03-31 | 141 pure |
| Medical Equipmentreportable segment | employees | at 2024-03-31 | 211 pure |
| Particle Countersreportable segment | employees | at 2024-03-31 | 100 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,569
| Item | Context | Value | Unit |
|---|---|---|---|
| Assets | Prior1YearInstant | 34557469000 | JPY |
| Assets | CurrentYearInstant | 37140839000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 2475652000 | JPY |
| Notes and accounts payable trade | CurrentYearInstant | 2518711000 | JPY |
| Income taxes payable | Prior1YearInstant | 268150000 | JPY |
| Income taxes payable | CurrentYearInstant | 398273000 | JPY |
| Accrued consumption taxes | Prior1YearInstant | 20181000 | JPY |
| Accrued consumption taxes | CurrentYearInstant | 180340000 | JPY |
| Accrued expenses | Prior1YearInstant | 418930000 | JPY |
| Accrued expenses | CurrentYearInstant | 415479000 | JPY |
| Provision for bonuses | Prior1YearInstant | 1093183000 | JPY |
| Provision for bonuses | CurrentYearInstant | 1201372000 | JPY |
| Provision for product warranties | Prior1YearInstant | 207741000 | JPY |
| Provision for product warranties | CurrentYearInstant | 218022000 | JPY |
| Other cl | Prior1YearInstant | 303598000 | JPY |
| Other cl | CurrentYearInstant | 446286000 | JPY |
| Current liabilities | Prior1YearInstant | 4787438000 | JPY |
| Current liabilities | CurrentYearInstant | 5378486000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 1398949000 | JPY |
| Net defined benefit liability | CurrentYearInstant | 803869000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 66213000 | JPY |
| Deferred tax liabilities | CurrentYearInstant | 59535000 | JPY |
| Deferred tax liabilities for land revaluation | Prior1YearInstant | 1447734000 | JPY |
| Deferred tax liabilities for land revaluation | CurrentYearInstant | 1447734000 | JPY |
| Other ncl | Prior1YearInstant | 244791000 | JPY |
| Other ncl | CurrentYearInstant | 239845000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 3157689000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 2550985000 | JPY |
| Liabilities | Prior1YearInstant | 7945127000 | JPY |
| Liabilities | CurrentYearInstant | 7929471000 | JPY |
| Capital stock | Prior1YearInstant | 2043594000 | JPY |
| Capital stock | CurrentYearInstant | 2052306000 | JPY |
| Capital surplus | Prior1YearInstant | 2467093000 | JPY |
| Capital surplus | CurrentYearInstant | 2475805000 | JPY |
| Retained earnings | Prior1YearInstant | 18302038000 | JPY |
| Retained earnings | CurrentYearInstant | 20400637000 | JPY |
| Treasury stock | Prior1YearInstant | -10679000 | JPY |
| Treasury stock | CurrentYearInstant | -10728000 | JPY |
| Shareholders equity | Prior1YearInstant | 22802046000 | JPY |
| Shareholders equity | CurrentYearInstant | 24918021000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 519659000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 529092000 | JPY |
| Revaluation reserve for land | Prior1YearInstant | 3277067000 | JPY |
| Revaluation reserve for land | CurrentYearInstant | 3277067000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -110369000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | -44995000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 123937000 | JPY |
| Remeasurements of defined benefit plans | CurrentYearInstant | 532182000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 3810294000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 4293346000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |